1.中国中医科学院广安门医院,北京市西城区北线阁5号,100053
2.北京大学公共卫生学院
3.四川大学华西医院中国循证医学中心
zylzy501@163.com
收稿:2022-05-09,
修回:2022-09-08,
纸质出版:2022-12-02
移动端阅览
王学谦,贾金柱,李玲等.将症状阈值事件数引入中医治疗恶性肿瘤疗效评价体系的探讨[J].中医杂志,2022,63(23):2201-2206.
WANG Xueqian,JIA Jinzhu,LI Ling,et al.Discussion on the Application of Symptom Threshold Events in the Efficacy Evaluation System of Treating Malignant Tumors in Traditional Chinese Medicine[J].Journal of Traditional Chinese Medicine,2022,63(23):2201-2206.
王学谦,贾金柱,李玲等.将症状阈值事件数引入中医治疗恶性肿瘤疗效评价体系的探讨[J].中医杂志,2022,63(23):2201-2206. DOI: 10.13288/j.11-2166/r.2022.23.001.
WANG Xueqian,JIA Jinzhu,LI Ling,et al.Discussion on the Application of Symptom Threshold Events in the Efficacy Evaluation System of Treating Malignant Tumors in Traditional Chinese Medicine[J].Journal of Traditional Chinese Medicine,2022,63(23):2201-2206. DOI: 10.13288/j.11-2166/r.2022.23.001.
症状管理是中医药治疗恶性肿瘤的重要优势之一,但因缺少能够充分体现中医肿瘤临床实践特点的症状疗效评价方法,而在一定程度上限制了中医药治疗肿瘤优势的发挥。症状阈值事件数评价指标已在国内外多个临床症状干预研究中得到使用,对其使用原理和特点分析发现,将该指标应用于中医肿瘤症状疗效评价,不仅符合中医药治疗肿瘤临床实践的基本原理,而且还满足现代医学对评价指标客观化、标准化的要求。通过阐述症状阈值事件数评价指标的概念、具体研究方法以及其应用于中医肿瘤症状疗效评价的优势和不足,进而分析探讨将症状阈值事件数引入中医恶性肿瘤疗效评价体系的科学性、可行性和实用性,以期为中医肿瘤症状管理疗效评价提供新的思路和参考。
Symptom management is one most important advantage of traditional Chinese medicine (TCM) in the treatment of malignant tumors. However, due to the lack of symptomatic efficacy evaluation methods that can fully reflect the clinical practice characteristics of TCM, its advantages in treating tumors are partially limited. The symptom threshold events (STE) has been used in many clinical symptom related intervention studies at home and abroad. After analyzing the application principle and characteristics of STE, it is considered suitable for the efficacy evaluation of TCM symptoms in treating tumors, not only conforming to the basic principles of clinical practice of TCM in tumors, but also meeting the requirements of modern medicine for the objectification and standardization of evaluation indicators. By summarizing the concept of the evaluation index STE, the specific research methods, and the related advantages and limitations in applying it to the efficacy evaluation of TCM symptoms in treating tumors, this paper further discussed the scientificity, feasibility and practicality of introducing STE into the efficacy evaluation system of TCM malignant tumors, so as to provide new ideas and references for the efficacy evaluation of TCM symptoms in tumor management.
赫捷 . 临床肿瘤学 [M]. 2版 . 北京 : 人民卫生出版社 , 2020 : 382 - 386 .
王学谦 , 侯炜 , 郑佳彬 , 等 . 中医综合治疗方案维持治疗晚期非小细胞肺癌的多中心、大样本、前瞻性队列研究 [J]. 中医杂志 , 2020 , 61 ( 8 ): 690 - 694 .
黄雨滟 , 彭博 , 陈佩云 , 等 . 针灸对芳香化酶抑制剂诱导乳腺癌病人关节症状干预的有效性 [J]. 西南医科大学学报 , 2022 , 45 ( 4 ): 344 - 350 .
关佳瑞 , 张彭 , 谢洋 . 肺癌患者报告结局测评工具的研究近况与思考 [J]. 世界中医药 , 2022 , 17 ( 17 ): 2490 - 2495 .
CLEELAND CS , WANG XS , SHI Q , et al . Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial [J]. J Clin Oncol , 2011 , 29 ( 8 ): 994 - 1000 .
符宇 , 邵明义 , 燕树勋 , 等 . 真实世界研究与中医临床疗效评价 [J]. 中医杂志 , 2019 , 60 ( 7 ): 546 - 550 .
GUI YR , ZHANG Y , WANG XQ , et al . Treatment of lung cancer with orally administered Chinese herbal medicine: an evidence map between 1970-2020 [J]. Chin J Integr Med , 2022 , 28 ( 10 ): 930 - 938 .
潘敏求 , 蒋益兰 , 潘博 , 等 . 安替可胶囊治疗中晚期恶性肿瘤30例临床观察 [J]. 中国中医药科技 , 1999 , 6 ( 1 ): 50 - 51 .
黎炜力 , 刘凤斌 . 中医药领域症状量化的现状、问题与展望 [C]// 中华中医药学会脾胃病分会第二十四次全国脾胃病学术交流会论文汇编 . 昆明 : 中华中医药学会 , 2012 : 639 - 643 .
郑筱萸 . 中药新药临床研究指导原则(试行) [M]. 北京 : 中国医药科技出版社 , 2002 .
王学谦 , 张英 , 刘杰 , 等 . 自拟皮疹颗粒治疗EGFR-TKI相关皮疹的随机对照研究 [J]. 世界中西医结合杂志 , 2016 , 11 ( 12 ): 1629 - 1632,1649 .
王烁 , 王学谦 , 王丹丹 , 等 . 中医肿瘤领域症状评价现状、问题及对策 [J]. 世界中医药 , 2022 , 17 ( 2 ): 251 - 254,260 .
CLEELAND CS , MENDOZA TR , WANG XS , et al . Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory [J]. Cancer , 2000 , 89 ( 7 ): 1634 - 1646 .
HOLLEN PJ , GRALLA RJ , MG KRIS , et al . Normative data and trends in quality of life from the lung cancer symptom scale (LCSS) [J]. Support Care Cancer , 1999 , 7 ( 3 ): 140 - 148 .
DAI W , FENG W , ZHANG Y , et al . Patient-Reported Outcome-Based symptom management versus usual care after lung cancer surgery: a multicenter randomized controlled trial [J]. J Clin Oncol , 2022 , 40 ( 9 ): 988 - 996 .
MENDOZA TR , WANG XS , LU C , et al . Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory [J]. Oncologist , 2011 , 16 ( 2 ): 217 - 227 .
HERSHMAN DL , UNGER JM , GREENLEE H , et al . Effect of acupuncture vs sham acupuncture or waitlist control on joint pain related to aromatase inhibitors among women with early-stage breast cancer: a rando-mized clinical trial [J]. JAMA , 2018 , 320 ( 2 ): 167 - 176 .
YANG JW , WANG LQ , ZOU X , et al . Effect of acupuncture for postprandial distress syndrome: a rando-mized clinical trial [J]. Ann Intern Med , 2020 , 172 ( 12 ): 777 - 785 .
JIAO L , XU J , SUN J , et al . Chinese herbal medicine combined with egfr-tki in egfr mutation-positive advanced pulmonary adenocarcinoma (catla): a multicenter, randomized, double-blind, placebo-controlled trial [J]. Front Pharmacol , 2019 , 10 : 732 . doi: 10.3389/fphar. 2019.00732 http://dx.doi.org/10.3389/fphar.2019.00732 .
VAPORCIYAN A , WANG XS , BASHKAR S , et al . A novel system for measuring longitudinal postoperative symptom burden: proof of concept comparing VATS versus open lobectomy [J]. Innovation , 2008 , 3 ( 2 ): 63 .
DAI W , ZHANG Y , FENG W , et al . Using patient-reported outcomes to manage postoperative symptoms in patients with lung cancer: protocol for a multicenter, randomized controlled trial [J]. BMJ Open , 2019 , 9 : e030041 . doi: 10.1136/ bmjopen-2019-030041 http://dx.doi.org/10.1136/bmjopen-2019-030041 .
SERLIN RC , MENDOZA TR , NAKAMURA Y , et al . When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function [J]. Pain , 1995 , 61 ( 2 ): 277 - 284 .
CHARLES SC , MICHAEL JF , ADRIAN JD . 癌症症状学评测、机制和管理 [M].张宏艳,李小梅,主译. 北京 : 人民卫生出版社 , 2019 : 250 - 251 .
0
浏览量
0
下载量
6
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号